Wegovy highlights of prescribing information, Novo Nordisk (2024) The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon-like peptide-1 receptor agonist therapy, Scientific Reports (2024) Decreased risk of anxiety in diabetic patients receiving glucagon-like peptide-1 receptor agonist: A nationwide, population-based cohort study, Frontiers in Pharmacology (2022) Most GLP-1 medications correlated with a lower likelihood of anxiety and depression diagnoses, Epic Research (2024) Dopamine release in the midbrain promotes anxiety, Biological Psychology (2021) Dopamine primes the brain for enhanced vigilance, MIT News (2018) Why your cardiologist may prescribe semaglutide (Wegovy), Yale Medicine (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

However, paresthesias is also a common symptom of nerve damage caused by high blood sugar in people with diabetes this is called diabetic peripheral neuropathy
For example, if you're a strict vegan or have genetics that affect carnitine levels, dietary supplements are likely necessary for you
J Am Soc Nephrol (2021) 32(2):27989
The route matters because GHK-Cu, like most peptides, is poorly absorbed orally digestive enzymes break it down before it can act systemically